Sort   by:  
 Page size 
UnknownRecent Advanced in the Treatment of Advanced SCC Tumors.
Not available
S-EPMC8833343 | biostudies-literature
UnknownUpdate in the Management of Basal Cell Carcinoma.
Not available
S-EPMC9189749 | biostudies-literature
UnknownPembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).
Not available
S-EPMC7460151 | biostudies-literature
UnknownAdoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
Not available
S-EPMC5883986 | biostudies-literature
UnknownVismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.
Not available
S-EPMC8093898 | biostudies-literature
UnknownA large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.
Not available
S-EPMC4003837 | biostudies-literature
UnknownHealth-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Not available
S-EPMC8484388 | biostudies-literature
UnknownExpert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
Not available
S-EPMC10265500 | biostudies-literature
UnknownHigh response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
Not available
S-EPMC10936461 | biostudies-literature
UnknownMechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
Not available
S-EPMC4773169 | biostudies-literature
Sort   by:  
 Page size